Dr. Martens Plc (DOCS) Q2 2026 Earnings Report

152 Followers

Previous Report: Q4 2025

Next Report: Q4 2026

GB:DOCS Q2 2026 EPS Results

Actual EPS>-£0.01

Consensus EPS>-£0.01

Beat/MissMet expectations

One Year Ago EPS-£0.01

GB:DOCS Q2 2026 Revenue Results

Actual Revenue£322.00M

Expected Revenue£326.71M

Beat/MissMissed by -£4.71M

YoY Revenue Growth-0.80%

Earnings Announcement Details

QuarterQ2 2026

Date11/20/2025

TimeBefore Open

Conference CallThursday, November 20, 2025

GB:DOCS Upcoming Earnings

Dr. Martens Plc's next earnings date is estimated for November 19, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

Q2 2026

Earnings Call Date:Nov 20, 2025|

% Change Since:

Earnings Call Sentiment|Neutral

The earnings call presented a mix of positive and negative aspects. There was notable improvement in revenue quality, operating profit, and debt reduction. Growth was observed in the Americas and APAC regions, along with an increase in full-price sales. However, challenges in the EMEA market, particularly in direct-to-consumer revenue, and ongoing issues with boots and sandals, along with tariff headwinds, were highlighted as areas of concern.

Company Guidance

During the call, the company provided guidance indicating strong performance in key metrics and adherence to their strategic plan. They reported a year-on-year revenue increase of GBP 2.7 million, reaching GBP 327.3 million, with a focus on improving revenue quality through full-price sales. Operating profit improved by GBP 6.5 million, shifting from a loss last year to a GBP 3.4 million profit. However, the profit before tax remains a loss, albeit significantly improved from the previous year. The company's dividend was declared at 0.85p, and net bank debt decreased by GBP 33 million to GBP 154 million. The strategy included focusing on reducing markdowns, expanding product offerings, and leveraging partnerships in new markets. The company also emphasized cost control, with a net debt-to-EBITDA ratio finishing at 2.1x, and aimed for sustainable growth in FY '27 and beyond.

Revenue Growth and Quality Improvement

Revenue increased by GBP 2.7 million to GBP 327.3 million year-on-year, with a focus on full price sales and a reduction in markdown sales, resulting in better revenue quality.

Operating Profit Improvement

Operating profit improved by GBP 6.5 million, swinging from a loss last year to a GBP 3.4 million profit this year, despite some headwinds.

Significant Debt Reduction

Net bank debt reduced by GBP 33 million year-on-year to GBP 154 million, showing strong balance sheet management.

Growth in the Americas and APAC

The Americas returned to growth with a GBP 4.8 million increase in DTC, and APAC saw continued year-on-year growth, especially in South Korea retail.

Full-Price Sales Increase

DTC full-price revenue is up 6% year-on-year, with a 10% increase in new consumers buying at full price.

GB:DOCS Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 19, 2026	2027 (Q2)	<0.01 / -	-0.009	―
May 19, 2026	2026 (Q4)	0.04 / 0.04	0.036	16.67% (<+0.01)
Nov 20, 2025	2026 (Q2)	>-0.01 / >-0.01	-0.013	30.77% (<+0.01)
Jun 05, 2025	2025 (Q4)	0.03 / 0.04	0.051	-29.41% (-0.01)
Nov 28, 2024	2025 (Q2)	-0.02 / -0.01	0.019	-168.42% (-0.03)
May 30, 2024	2024 (Q4)	0.05 / 0.05	0.084	-39.29% (-0.03)
Nov 30, 2023	2024 (Q2)	0.02 / 0.02	0.045	-57.78% (-0.03)
Jun 01, 2023	2023 (Q4)	0.10 / 0.08	0.132	-36.36% (-0.05)
Nov 24, 2022	2023 (Q2)	0.04 / 0.04	0.048	-6.25% (>-0.01)
Jun 01, 2022	2022 (Q4)	0.08 / 0.13	0.082	60.98% (+0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed